Xiaoxue Ren

789 total citations · 1 hit paper
9 papers, 373 citations indexed

About

Xiaoxue Ren is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Xiaoxue Ren has authored 9 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Xiaoxue Ren's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Immune cells in cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Xiaoxue Ren is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Immune cells in cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Xiaoxue Ren collaborates with scholars based in China, Hong Kong and Singapore. Xiaoxue Ren's co-authors include Lixia Xu, Sui Peng, Jiaming Lai, Shenghua Zhu, Baogang Peng, Ming Kuang, Xiaoxing Li, Wanjie Zhu, Shuibin Lin and Cheng Huang and has published in prestigious journals such as Molecular Cell, Gastroenterology and Hepatology.

In The Last Decade

Xiaoxue Ren

9 papers receiving 371 citations

Hit Papers

N7-Methylguanosine tRNA modification enhances oncogenic m... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Xiaoxue Ren
Xuxin Ren China
Dennis Poel Netherlands
Betül Gök Yavuz United States
Xuxin Ren China
Xiaoxue Ren
Citations per year, relative to Xiaoxue Ren Xiaoxue Ren (= 1×) peers Xuxin Ren

Countries citing papers authored by Xiaoxue Ren

Since Specialization
Citations

This map shows the geographic impact of Xiaoxue Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxue Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxue Ren more than expected).

Fields of papers citing papers by Xiaoxue Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxue Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxue Ren. The network helps show where Xiaoxue Ren may publish in the future.

Co-authorship network of co-authors of Xiaoxue Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxue Ren. A scholar is included among the top collaborators of Xiaoxue Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxue Ren. Xiaoxue Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Ying, Weixin Liu, Chi Chun Wong, et al.. (2025). Catenibacterium mitsuokai promotes hepatocellular carcinogenesis by binding to hepatocytes and generating quinolinic acid. Cell Metabolism. 37(10). 1998–2013.e7. 2 indexed citations
2.
Ren, Xiaoxue, et al.. (2025). Clonorchis sinensis Promotes Intrahepatic Cholangiocarcinoma Progression by Activating FASN‐Mediated Fatty Acid Metabolism. Journal of Gastroenterology and Hepatology. 40(4). 1004–1015. 1 indexed citations
3.
Ren, Xiaoxue, Yubin Xie, Yifan Wu, et al.. (2023). Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. Cell Reports Medicine. 4(11). 101277–101277. 29 indexed citations
4.
Chen, Zhihang, Xiaoxue Ren, Qian Zhou, et al.. (2023). Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer. Cancer Research. 83(21). 3544–3561. 33 indexed citations
5.
Song, Zimin, Xiaoxue Ren, Nian Wang, et al.. (2023). Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes. Hepatology International. 17(5). 1300–1317. 10 indexed citations
6.
Ren, Xiaoxue, et al.. (2023). 600 PERSONALIZED DRUG SCREENING IN PATIENT-DERIVED ORGANOIDS OF BILIARY TRACT CANCER AND ITS CLINICAL APPLICATION. Gastroenterology. 164(6). S–1255. 1 indexed citations
7.
Li, Meiyi, Lina Wang, Cong Liang, et al.. (2023). Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Hepatology. 79(3). 560–574. 52 indexed citations
8.
Ren, Xiaoxue, et al.. (2022). Patient‐derived cancer organoids for drug screening: Basic technology and clinical application. Journal of Gastroenterology and Hepatology. 37(8). 1446–1454. 44 indexed citations
9.
Dai, Zihao, Hai‐Ning Liu, Junbin Liao, et al.. (2021). N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Molecular Cell. 81(16). 3339–3355.e8. 201 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026